Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Biosion, Inc. Appoints Dr. Rakesh Dixit, ADC Thought Leader, to Advisory Board 2022-09-07 20:54
Lianhua Products Designated as Epidemic Prevention Supplies : 2022 CIFTIS 2022-09-07 20:15
Tycoon Group Signs Cooperation Agreement with JD Logistics, Obtains Operating Rights of Logistics Supply Chain Industry Bases in France 2022-09-07 20:13
GenFleet Therapeutics to Present Data from Phase I Trial of GFH018 Monotherapy at the 2022 European Society for Medical Oncology Annual Meeting 2022-09-07 19:00
Waterdrop Announces Appointment of a New Director 2022-09-07 16:54
Laekna Announces First Patient Dosed in South Korea in LAE201INT2101 Phase 1/2 Study 2022-09-06 17:02
Amcor reveals Lift-Off seed capital winners with investments that seek to "drive the revolution in packaging" 2022-09-06 16:10
Jacobio Receives CDE Approval for KRAS G12C Inhibitor JAB-218822's Phase II Pivotal Study in China 2022-09-06 15:20
Dizal Announces Sunvozertinib Meets Primary Endpoint in its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMO 2022-09-05 22:49
Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMO 2022-09-05 22:39
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US 2022-09-05 21:09
Lunit to Showcase 5 Abstracts at ESMO 2022 2022-09-05 21:00
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives 2022-09-05 16:00
Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue 2022-09-05 13:09
Tamas Oravecz Ph.D. named SVP, CSO of the U.S. of Simcere Pharmaceutical Group 2022-09-05 13:08
New Building Stands as Symbol of Dignity and Hope For Persons Affected by Leprosy in Ethiopia 2022-09-02 22:00
Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products 2022-09-02 20:50
Waterdrop Inc. to Report Second Quarter 2022 Financial Results on September 9, 2022 2022-09-02 20:00
Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China 2022-09-02 19:00
Jacobio Completes First Dose of IIa Clinical Trial of JAB-21822 on KRAS G12C and STK11 Co-mutation in China 2022-09-02 17:14
1 129 130 131 132 133 801